DS
TRAW icon

David Shaw’s Traws Pharma TRAW Stock Holding History

David Shaw’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Hold
0
– -$64K – 3903
2015
Q1 		– Sell
-1
Closed -$164K – 3551
2014
Q4 		$107K Buy
+1
New +$245K ﹤0.01% 3898

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HK
Horizon Kinetics New York $3.06B AUM 5.37% 1-Year Est. Return

David Shaw's TRAW Position: Q2 2015 in Review

David Shaw held its Traws Pharma (TRAW) position steady in Q2 2015 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3903.

David Shaw first reported a position in TRAW in Q4 2014 and has held it in 1 quarter since. The position peaked at $107K in Q4 2014. 8 funds tracked by Wall St. Rank hold TRAW as of Q2 2015.

  • David Shaw held 0 shares of Traws Pharma worth $0 as of Q2 2015.
  • David Shaw left its Traws Pharma share count unchanged in Q2 2015.
  • Traws Pharma made up ﹤0.01% of David Shaw's portfolio in Q2 2015, its #3903 holding.
  • David Shaw first reported a position in Traws Pharma in Q4 2014 and has held it in 1 quarter since.
  • David Shaw's Traws Pharma position peaked at $107K in Q4 2014.
  • 8 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2015.

Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.